Nexalin Technology, Inc.SEC Filings
|
|
All SEC filings by Nexalin Technology, Inc. (NXL) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 12, 2026 | |
| ARS | Annual report to shareholders | Jul 10, 2026 | ||
| 10-Q | Quarterly report | View Diff | May 8, 2026 | |
| 10-K | Annual report | View Diff | Mar 25, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 14, 2025 | |
| 10-K/A | Annual report | View Diff | Sep 23, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 6, 2025 | |
| 10-Q | Quarterly report | View Diff | May 13, 2025 | |
| 10-K/A | Annual report | View Diff | Apr 14, 2025 | |
| 10-K | Annual report | View Diff | Mar 14, 2025 |
Events
| 8-K | Current report | Sep 2, 2026 | ||
| 8-K | Nexalin Technology Announces Reverse Stock Split | Aug 27, 2026 | ||
| 8-K | Current report | Aug 21, 2026 | ||
| 8-K | Current report | Aug 20, 2026 | ||
| 8-K | Current report | Aug 17, 2026 | ||
| 8-K | Current report | Aug 11, 2026 | ||
| 8-K | Current report | Jul 29, 2026 | ||
| 8-K | Current report | Jul 27, 2026 | ||
| 8-K | Current report | Jun 17, 2026 | ||
| 8-K | Nexalin Acquires Ai-Integrated Digital Health Platform Behind Halo™ Clarity and Nexalin Neurocare™ Ahead of Planned Fda Pivotal Trial | May 19, 2026 |
Registrations and Prospectuses
| S-1 | IPO registration | View Diff | Sep 3, 2026 | |
| 424B5 | Prospectus supplement for primary offering | Aug 20, 2026 | ||
| 424B5 | Prospectus supplement for primary offering | Oct 15, 2025 | ||
| 25-NSE | Exchange delisting | Sep 19, 2025 | ||
| 424B4 | Prospectus supplement with pricing info | May 6, 2025 | ||
| 424B5 | Prospectus supplement for primary offering | May 5, 2025 | ||
| 424B4 | Prospectus supplement with pricing info | May 2, 2025 | ||
| S-3 | Shelf registration | View Diff | Apr 23, 2025 | |
| DRSLTR | Correspondence regarding draft registration statement | Apr 10, 2025 | ||
| DRS | Draft registration statement | Mar 31, 2025 |
Proxies
Other
| EFFECT | Notice of effectiveness | Apr 30, 2025 | ||
| CORRESP | Correspondence with SEC | Apr 28, 2025 | ||
| UPLOAD | Letter from SEC | Apr 7, 2025 | ||
| EFFECT | Notice of effectiveness | Feb 4, 2025 | ||
| CORRESP | Correspondence with SEC | Jan 30, 2025 | ||
| UPLOAD | Letter from SEC | Jan 3, 2025 | ||
| EFFECT | Notice of effectiveness | Jun 28, 2024 | ||
| CORRESP | Correspondence with SEC | Jun 26, 2024 | ||
| CORRESP | Correspondence with SEC | Jun 26, 2024 | ||
| CORRESP | Correspondence with SEC | Jun 24, 2024 |
Ownership
| SC 13D | Greenlight Ventures, Llc Acquires Stake in Nexalin Technology, Inc. | Sep 3, 2026 | ||
| SC 13G | Alumni Capital Lp Acquires Stake in Nexalin Technology, Inc. | Aug 27, 2026 | ||
| 4 | Mark White | Dec 23, 2025 | ||
| 4 | Fleet Justin Van | Dec 23, 2025 | ||
| 4 | David Owens | Dec 23, 2025 | ||
| 4 | Carolyn Hamby Shelton | Dec 23, 2025 | ||
| 4 | Ben Hu | Dec 23, 2025 | ||
| 4 | Alan Kazden | Dec 23, 2025 | ||
| 4 | Leonard Osser | Sep 30, 2025 | ||
| 4 | David Owens | Sep 30, 2025 |